- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01877213
Coaching of Diabetic Patients After Hospital Discharge (SORTIDIAB)
May 2, 2017 updated by: Assistance Publique - Hôpitaux de Paris
Coaching of Difficult Diabetic Patients by a Care Coordinating Team After Hospital Discharge
One third of the costs of medical care for people with diabetes are related to hospitalization."
Difficult" diabetic patient, i.e. those with very high HbA1c, patients > 75y, those with diabetic foot ulcers, or those with a recent cardiovascular event have a high rate of readmission when discharged at home after an initial hospitalization related to diabetes or its complications.
The objective of the study is to test if a coaching with a care coordinating team after hospital discharge would decrease diabetes-related rehospitalization rate compared with usual care.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Patients with type 1 (T1D) or type 2 diabetes (T2D) hospitalized (>24h) and presenting at least a risk factor for readmission after discharge at home, will be randomized, at time of discharge, between 2 groups: an "intervention" group and a control group (usual management).
Intervention will consist in optimized organization of discharge at home followed by a ambulatory individualized coaching by a nurse including an initial situation assessment, a consultation meeting with the patient's GP in order to propose a Health Personalized Plan, then a follow up program with a face to face session each trimester in order to remind the objectives, to assess compliance to the plan, to evaluate difficulties encountered and to help to find solutions.
Final data collection will be done in both groups by questioning the patient's general practitioner (GP) and by collecting data on potential hospitalization.
Expected duration : 3 years.
Readmission rate, duration and causes of hospitalization will be compared between both groups.
Impact of the results : Reduction of costs, improved use of hospital specialized resources.
Study Type
Interventional
Enrollment (Anticipated)
600
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Le Kremlin-bicetre, France, 94 275
- Recruiting
- Assistance Publique - Hôpitaux de Paris, Bicêtre Hospital
-
Contact:
- Philippe CHANSON, MD, PhD
- Phone Number: + 33 1 45 21 37 08
- Email: philippe.chanson@bct.aphp.fr
-
Principal Investigator:
- Philippe CHANSON, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
type 1 or type 2 diabetes AND AT LEAST ONE of the following criteria:
- admission for more than 5 days
- unplanned admission
- at least one urgent care/emergency room visit in the 6 previous months, whatever its cause
- HbA1c > 10% on admission
- cardiovascular event in the previous year : cardiac failure, myocardial infarction, coronary or peripheral revascularization procedure, stage IV peripheral arteriopathy, stroke.
- occurence during the previous year of a foot lesion requiring an admission or lasting more than one month (foot lesion risk stage 3)
Exclusion Criteria:
- patients with one of the following co-morbidity: cancer in active phase of treatment, Parkinson's disease treated, severe chronic respiratory failure,
- refusal of signing the consent,
- patients non affiliated to Social Security,
- pregnant women,
- people who do not understand French (except if accompanied by somebody able to translate),
- renal dialysis,
- patients aged less than 18 years,
- patients already in a similar type of trial
- the arisen of a pregnancy or a cancer will cause the stop of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Coaching with coordinate care
After discharge from hospital, patients randomized in the coaching group will be coached by a coordinator nurse.
|
The coordinator nurse will manage ambulatory care with the patient's GP and participate to patient's education.
|
|
No Intervention: Usual care
After discharge from hospital, patients randomized in the no intervention group will be managed as usually.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diabetes-related readmissions
Time Frame: Up to 1 year
|
Recording of all readmissions and analysis of files and reports for determining if this readmission was related to diabetes or not.
|
Up to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Causes of rehospitalizations
Time Frame: Up to 1 year
|
Each admission to hospital (type of department, duration, direct admission or via Emergency room…) will be recorded.
All efforts will be made to record the cause of hospitalization.
|
Up to 1 year
|
|
Duration of rehospitalizations
Time Frame: Up to 1 year
|
Up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Philippe CHANSON, MD, PhD, Assistance Publique Hôpitaux de Paris - Bicêtre Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Anticipated)
June 1, 2017
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
June 11, 2013
First Submitted That Met QC Criteria
June 11, 2013
First Posted (Estimate)
June 13, 2013
Study Record Updates
Last Update Posted (Actual)
May 3, 2017
Last Update Submitted That Met QC Criteria
May 2, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P110602
- 2012-A00938-35 (Other Identifier: IRB number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
University of PennsylvaniaNational Institute on Aging (NIA); American Heart AssociationRecruitingType 2 Diabetes Mellitus | Type 2 Diabetes | Type II Diabetes Mellitus | Pre-diabetes | Pre-diabetic | Type II Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2DM) | Pre-diabetic StateUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on Coaching with coordinate care
-
Johns Hopkins UniversityEnrolling by invitationMultimorbidityUnited States
-
Tilburg UniversityElisabeth-TweeSteden Ziekenhuis; Verbeeten InstituteCompletedMyocardial Infarction | Myocardial Ischemia | Autonomic DysfunctionNetherlands
-
Emory UniversityCenters for Disease Control and PreventionCompletedSubstance Use DisordersUnited States
-
University of California, Los AngelesCompletedDepression | Anxiety | Pregnancy Related | Perinatal DepressionUnited States
-
Queen Mary University of LondonBarts & The London NHS TrustCompletedCardiovascular DiseaseUnited Kingdom
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedCancer | Insomnia | Insomnia Due to Medical ConditionUnited States
-
Hoag Memorial Hospital PresbyterianInstitute for Systems Biology; ArivaleCompletedCognitive Impairment | Alzheimer DiseaseUnited States
-
Dartmouth-Hitchcock Medical CenterCompleted
-
VA Office of Research and DevelopmentMinneapolis Veterans Affairs Medical Center; Corporal Michael J. Crescenz VA...Active, not recruitingStress Disorders, Post-traumaticUnited States
-
University of Kansas Medical CenterNational Institute of Nursing Research (NINR)CompletedProstate CancerUnited States